CTU: A randomised, double-blind, placebo-controlled, dose-finding study evaluating efficacy, safety, and tolerability of different oral doses of BI 1819479 over at least 24 weeks in patients with idiopathic pulmonary fibrosis (IPF)

Veitch, Elizabeth (Primary Chief Investigator)
Quinlan, Gabriel (Clinical Trial Unit Staff)
Chapman, Nicola (Clinical Trial Unit Staff)
TAIDI, Gina (Clinical Trial Unit Staff)
Martin, Lewis (Clinical Trial Unit Staff)
Garcia, Michelle (Clinical Trial Unit Staff)

Faculty of Medicine, Health and Human Sciences

Project: Research

Short title	1462-0004
Status	Active
Effective start/end date	26/08/24 → 26/06/29